Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -87.82%9.27M | 86.85%116.93M | 344.49%76.12M | 3.37%62.58M | -11.32%17.13M | -46.97%60.54M | -51.66%19.31M | 26.46%114.17M | 51.52%39.95M | 23.26%90.28M |
| Operating income | -87.82%9.27M | 86.85%116.93M | 344.49%76.12M | 3.37%62.58M | -11.32%17.13M | -46.97%60.54M | -51.66%19.31M | 26.46%114.17M | 51.52%39.95M | 23.26%90.28M |
| Cost of sales | 92.42%-5.3M | -167.09%-101.02M | -554.70%-69.94M | 26.68%-37.82M | 33.91%-10.68M | 43.45%-51.59M | 43.09%-16.17M | -35.63%-91.23M | -60.10%-28.4M | -45.71%-67.26M |
| Operating expenses | 92.42%-5.3M | -167.09%-101.02M | -554.70%-69.94M | 26.68%-37.82M | 33.91%-10.68M | 43.45%-51.59M | 43.09%-16.17M | -35.63%-91.23M | -60.10%-28.4M | -45.71%-67.26M |
| Gross profit | -35.83%3.97M | -35.74%15.91M | -4.05%6.18M | 176.68%24.76M | 104.73%6.44M | -60.99%8.95M | -72.75%3.15M | -0.35%22.94M | 33.86%11.55M | -15.00%23.02M |
| Selling expenses | -25.87%-180K | 83.87%-226K | 81.03%-143K | 36.49%-1.4M | 23.37%-754K | 51.93%-2.21M | 65.74%-984K | -5.76%-4.59M | -77.17%-2.87M | 3.47%-4.34M |
| Administrative expenses | 21.36%-11.37M | -30.94%-36.01M | 15.13%-14.46M | 25.37%-27.5M | -15.39%-17.04M | 4.68%-36.85M | 17.11%-14.77M | -5.90%-38.66M | 1.26%-17.81M | 12.23%-36.5M |
| Research and development expenses | 25.29%-1.09M | -51.82%-3.93M | 21.81%-1.46M | 38.69%-2.59M | -24.07%-1.87M | -6.11%-4.22M | 23.85%-1.5M | 5.22%-3.98M | 8.27%-1.98M | 76.49%-4.2M |
| Revaluation surplus | ---- | ---9.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of financial assets | ---- | ---9.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -37.21%-6.56M | 79.75%-2.47M | -296.75%-4.78M | -50.92%-12.2M | -20.54%2.43M | 91.10%-8.08M | 314.00%3.06M | -2,092.26%-90.85M | -146.68%-1.43M | 91.28%4.56M |
| -Other impairment is provision | -37.21%-6.56M | 79.75%-2.47M | -296.75%-4.78M | -50.92%-12.2M | -20.54%2.43M | 91.10%-8.08M | 314.00%3.06M | -2,092.26%-90.85M | -146.68%-1.43M | 91.28%4.56M |
| Special items of operating profit | -63.41%330K | -64.92%2.47M | -67.39%902K | 31.12%7.04M | -37.84%2.77M | -17.19%5.37M | -13.39%4.45M | 63.52%6.49M | 95.21%5.14M | -28.34%3.97M |
| Operating profit | -8.32%-14.9M | -181.58%-33.46M | -71.60%-13.76M | 67.92%-11.88M | -21.52%-8.02M | 65.91%-37.04M | 10.87%-6.6M | -705.30%-108.64M | 1.23%-7.4M | 53.37%-13.49M |
| Financing cost | 96.97%-36K | 28.88%-2.35M | 31.01%-1.19M | 12.53%-3.31M | 13.07%-1.72M | 8.97%-3.78M | 1.64%-1.98M | -8.34%-4.16M | -5.39%-2.01M | 39.69%-3.84M |
| Share of profits of associates | ---- | ---- | ---- | 10.37%-2.56M | 75.37%-67K | -207.65%-2.86M | 49.44%-272K | -5.94%-928K | -647.22%-538K | -7,200.00%-876K |
| Earning before tax | 0.05%-14.94M | -101.75%-35.81M | -52.41%-14.95M | 59.35%-17.75M | -10.80%-9.81M | 61.60%-43.68M | 11.09%-8.85M | -524.74%-113.73M | -5.03%-9.96M | 48.44%-18.2M |
| Tax | -600.00%-7K | -6.25%-17K | 87.50%-1K | -300.00%-16K | -100.00%-8K | 91.11%-4K | 55.56%-4K | -103.43%-45K | -100.93%-9K | -37.86%1.31M |
| After-tax profit from continuing operations | 0.01%-14.95M | -101.66%-35.83M | -52.30%-14.95M | 59.32%-17.77M | -10.84%-9.82M | 61.61%-43.68M | 11.13%-8.86M | -573.57%-113.77M | -17.06%-9.96M | 49.11%-16.89M |
| Earning after tax | 0.01%-14.95M | -101.66%-35.83M | -52.30%-14.95M | 59.32%-17.77M | -10.84%-9.82M | 61.61%-43.68M | 11.13%-8.86M | -573.57%-113.77M | -17.06%-9.96M | 56.12%-16.89M |
| Minority profit | -57.95%-2.57M | -4,743.06%-3.34M | -60.65%-1.63M | 102.66%72K | -30.17%-1.01M | 33.87%-2.71M | 28.99%-779K | -132.94%-4.1M | -172.89%-1.1M | -1,040.11%-1.76M |
| Profit attributable to shareholders | 7.10%-12.37M | -82.11%-32.49M | -51.34%-13.32M | 56.46%-17.84M | -8.98%-8.8M | 62.64%-40.97M | 8.92%-8.08M | -624.76%-109.68M | -9.33%-8.87M | 60.87%-15.13M |
| Basic earnings per share | 24.38%-0.0276 | -36.67%-0.082 | -20.07%-0.0365 | 62.62%-0.06 | 5.59%-0.0304 | 64.90%-0.1605 | -329.33%-0.0322 | -3,010.88%-0.4573 | 5.06%-0.0075 | 66.51%-0.0147 |
| Diluted earnings per share | 24.38%-0.0276 | -36.67%-0.082 | -20.07%-0.0365 | 62.62%-0.06 | 5.59%-0.0304 | 64.90%-0.1605 | -329.33%-0.0322 | -3,010.88%-0.4573 | 5.06%-0.0075 | 66.51%-0.0147 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Pak Chun Certified Public Accountants Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.